BUZZ-美国银行上调评级,Regeneron Pharma 获利

路透中文
Jan 08
BUZZ-<a href="https://laohu8.com/S/BAC">美国银行</a>上调评级,Regeneron Pharma 获利

1月7日 - ** 制药商Regeneron PharmaceuticalsREGN.O股价上涨3.7%,报805.32美元

** 美国银行全球研究将该公司评级从 "跑输大市 "上调至 "买入";将PT从627美元上调至860美元。

** 新的PT较上一交易日收盘价上涨约11

** 鉴于标签更新,券商对新版眼药 Eylea SD 的看法更为积极

** 我们认为 Dupixent 和进入 2026 年的后期管线资产将带来可观的上涨空间" - BofA

** 2025 年股价上涨 8.4

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10